Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health ...
TD Cowen (formerly Cowen Inc.), is an American multinational investment bank and financial services division of TD Securities that operates through two business segments: a broker-dealer and an investment management division.
The company's broker-dealer division offers investment banking services, ...
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Oil holds steady after 5-day winning streak; set for weekly surge on Iran conflict Trump replaces Homeland Security chief Kristi Noem Wall Street ends lower on escalating Iran conflict, report of AI export curbs Trump says he must be involved in selecting Iran’s next leader (South Africa Philippines Nigeria) TD Cowen downgrades Enhabit stock rating on Kinderhook buyout By Analyst Ratings Published 03/06/2026, 01:47 AM TD Cowen downgrades Enhabit stock rating on Kinderhook buyout 0 EHAB 0.00% Investing.com - TD Cowen downgraded Enhabit Home Health & Hospice (NYSE:EHAB) to Hold from Buy and raised its price target to $13.80 from $12.00. The new price target reflects the proposed all-cash acquisition price of $13.80 per share by private equity firm Kinderhook, which was announced on February 23, 2026. The stock currently trades at $13.61, just below its 52-week high of $13.64, following a remarkable 70% gain over the past year. According to InvestingPro analysis, the company appears overvalued at current levels relative to its Fair Value estimate. TD Cowen analyst Ryan Langston said the price target represents 9.6 times the firm’s 2027 adjusted EBITDA-NCI estimate for the home health and hospice provider. The firm updated its model to reflect fourth-quarter 2025 earnings results. TD Cowen maintained its 2026 and 2027 EBITDA estimates at $106 million and $116 million, respectively, compared to the company’s last twelve months EBITDA of $86 million. For deeper insights into EHAB’s valuation and growth prospects, investors can access the comprehensive Pro Research Report, available for this and 1,400+ other US equities on InvestingPro . In other recent news, Enhabit Home Health & Hospice announced a definitive agreement to be acquired by Kinderhook Industries in an all-cash transaction valued at approximately $1.1 billion. Shareholders will receive $13.80 per share, marking a premium of about 24% over the previous ...
